Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
about
Chemotherapy for brain metastases from small cell lung cancerChemotherapy versus best supportive care for extensive small cell lung cancerTreatment for small cell lung cancer, where are we now?-a reviewResearch Progression of Maintenance Therapy in Small Cell Lung CancerPhase II trial of paclitaxel and cisplatin in patients with extensive stage small cell lung cancer: Cancer and Leukemia Group B Trial 9430.Duration of chemotherapy for small cell lung cancer: a meta-analysis.Chemotherapy of lung cancer: A global perspective of the role of ifosfamideDoes maintenance/consolidation chemotherapy have a role in the management of small cell lung cancer (SCLC)? A metaanalysis of the published controlled trials.Small cell lung cancer: treatment review.Current concepts in the management of small cell lung cancer.A multicenter, randomized, Phase II study of cisplatin, etoposide, and gemcitabine or cisplatin plus gemcitabine as first-line treatment in patients with poor-prognosis small cell lung carcinoma.Phase II study of oral etoposide maintenance for patients with extensive stage small cell lung cancer who have responded to the induction on an EP regimen.Small Cell Lung Cancer.Combining drugs and extending treatment - a PFS end point is not sufficient.
P2860
Q24202771-29A920CA-0B59-48FE-AAFE-A445EC57F1A4Q24240652-FF26BC86-2988-4605-99C6-E93482AEEAA6Q26767023-9E2EB355-469F-4154-9458-C6F4A05A58DFQ26783450-CD725128-3947-40CD-84A7-87FFEFCDB15CQ33381874-05E5F5B1-94DF-469D-BE85-3192AA3E6AFAQ34983763-112509C3-B97D-4612-96F7-B0A8807EE293Q35200383-1C7D4974-FD56-44A2-A04C-07275F792A4AQ36311998-C6B18B45-1EFD-43A8-A883-AF239C2B2FF8Q36458604-E074774B-8D86-4D63-9AD8-A3DB75FFAD18Q37073202-F4F56C9D-9EC7-43F1-B0F7-A60BB578F962Q45217486-5682952A-EACF-4E92-81B7-466EB080249AQ50050385-89755CAC-8B8E-4580-906D-5D3F8586D968Q52853801-B602DF83-7D95-4F27-8C02-630577445C66Q53110057-59845BE4-2F93-4A93-9D60-34659A7CEADC
P2860
Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer: a Hoosier Oncology Group randomized study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Maintenance daily oral etoposi ...... cology Group randomized study.
@en
Maintenance daily oral etoposi ...... cology Group randomized study.
@nl
type
label
Maintenance daily oral etoposi ...... cology Group randomized study.
@en
Maintenance daily oral etoposi ...... cology Group randomized study.
@nl
prefLabel
Maintenance daily oral etoposi ...... cology Group randomized study.
@en
Maintenance daily oral etoposi ...... cology Group randomized study.
@nl
P2093
P356
P1433
P1476
Maintenance daily oral etoposi ...... cology Group randomized study.
@en
P2093
A B Sandier
L H Einhorn
P J Loehrer
P304
P356
10.1093/ANNONC/MDF014
P577
2002-01-01T00:00:00Z